DK2996706T3 - Apolipoprotein-mimetika og anvendelser deraf - Google Patents

Apolipoprotein-mimetika og anvendelser deraf

Info

Publication number
DK2996706T3
DK2996706T3 DK14769489.7T DK14769489T DK2996706T3 DK 2996706 T3 DK2996706 T3 DK 2996706T3 DK 14769489 T DK14769489 T DK 14769489T DK 2996706 T3 DK2996706 T3 DK 2996706T3
Authority
DK
Denmark
Prior art keywords
applications
apolipoprotein mimetics
apolipoprotein
mimetics
Prior art date
Application number
DK14769489.7T
Other languages
Danish (da)
English (en)
Inventor
Dennis Goldberg
Gattadahalli M Anantharamaiah
Original Assignee
Uab Research Foundation
Lipimetix Dev Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation, Lipimetix Dev Llc filed Critical Uab Research Foundation
Application granted granted Critical
Publication of DK2996706T3 publication Critical patent/DK2996706T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK14769489.7T 2013-03-14 2014-03-14 Apolipoprotein-mimetika og anvendelser deraf DK2996706T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361782956P 2013-03-14 2013-03-14
US201361834992P 2013-06-14 2013-06-14
PCT/US2014/027719 WO2014152776A1 (en) 2013-03-14 2014-03-14 Apolipoprotein mimetics and uses thereof

Publications (1)

Publication Number Publication Date
DK2996706T3 true DK2996706T3 (da) 2019-10-21

Family

ID=51581312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14769489.7T DK2996706T3 (da) 2013-03-14 2014-03-14 Apolipoprotein-mimetika og anvendelser deraf

Country Status (12)

Country Link
US (1) US20160002315A1 (cg-RX-API-DMAC7.html)
EP (1) EP2996706B1 (cg-RX-API-DMAC7.html)
JP (2) JP6570511B2 (cg-RX-API-DMAC7.html)
AU (2) AU2014239186B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015022624A2 (cg-RX-API-DMAC7.html)
CA (1) CA2903869A1 (cg-RX-API-DMAC7.html)
DK (1) DK2996706T3 (cg-RX-API-DMAC7.html)
ES (1) ES2753381T3 (cg-RX-API-DMAC7.html)
IL (1) IL240787B (cg-RX-API-DMAC7.html)
MX (1) MX2015012818A (cg-RX-API-DMAC7.html)
NZ (1) NZ713291A (cg-RX-API-DMAC7.html)
WO (1) WO2014152776A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3189069B1 (en) 2014-07-31 2024-10-23 UAB Research Foundation Apoe mimetic peptides and higher potency to clear plasma cholesterol
WO2017120568A1 (en) * 2016-01-08 2017-07-13 Lipimetix Development, Inc. Apoe mimetic peptide compositions
IL260931B2 (en) * 2016-02-17 2024-09-01 Regeneron Pharma Methods of treating or preventing atherosclerosis by blocking ANGPTL3
WO2017151783A1 (en) 2016-03-03 2017-09-08 Regeneron Pharmaceuticals, Inc. Methods for treating patients with hyperlipidemia by administering a pcsk9 inhibitor in combination with an angptl3 inhibitor
EP4384199A4 (en) * 2021-08-11 2025-07-02 The Regents Of Univ Of California PEPTIDES FOR MEMBRANES RETAINING A BARRIER FUNCTION

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
GB9022788D0 (en) 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US5331573A (en) 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
US5631280A (en) 1995-03-29 1997-05-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6506880B2 (en) 1998-03-17 2003-01-14 The Uab Research Foundation Synthetic peptides that enhance atherogenic lipoprotein uptake and lower plasma cholesterol
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
AU2008296487A1 (en) 2007-08-28 2009-03-12 The Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
EP2521564B1 (en) * 2010-01-06 2016-11-16 Cognosci, Inc. Apoe peptide dimers and uses thereof
EP3189069B1 (en) * 2014-07-31 2024-10-23 UAB Research Foundation Apoe mimetic peptides and higher potency to clear plasma cholesterol

Also Published As

Publication number Publication date
AU2017203911B2 (en) 2019-03-07
ES2753381T3 (es) 2020-04-08
MX2015012818A (es) 2016-05-12
EP2996706A1 (en) 2016-03-23
BR112015022624A2 (pt) 2017-10-31
AU2017203911A1 (en) 2017-06-29
JP2016515137A (ja) 2016-05-26
NZ713291A (en) 2017-04-28
JP6772317B2 (ja) 2020-10-21
EP2996706B1 (en) 2019-07-31
IL240787B (en) 2019-07-31
IL240787A0 (en) 2015-10-29
JP6570511B2 (ja) 2019-09-04
AU2014239186A1 (en) 2015-10-08
JP2019089834A (ja) 2019-06-13
EP2996706A4 (en) 2017-01-18
CA2903869A1 (en) 2014-09-25
AU2014239186B2 (en) 2017-04-20
WO2014152776A1 (en) 2014-09-25
US20160002315A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
DK3043784T3 (da) Arylethere og anvendelser deraf
EP2972846A4 (en) INTEGRATION FOR APPLICATIONS AND CONTAINERS
IL244744B (en) Matrix metalloproteinase cleavable polypeptides and uses thereof
DK3089994T3 (da) Fabs-in-tandem-immunglobulin og anvendelser deraf
DK3192869T3 (da) Isoleret oligonukleotid og anvendelse deraf i nukleinsyresekvensering
DK3480213T3 (da) Syntac-polypeptider og anvendelser deraf
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
DK3683235T3 (da) Anti-IL-33-antistoffer og anvendelser deraf
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
DK2968443T3 (da) Hepcidinanaloger og anvendelser deraf
IL266462B (en) Thrombin cleavable linker with xten and its uses thereof
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3027204T3 (da) Flerdelte signaleringsproteiner og anvendelser deraf
DK3052485T3 (da) Heterocykliske forbindelser og anvendelser deraf
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
DK3030549T3 (da) Pyridazinonforbindelser og anvendelser deraf
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK3058936T3 (da) Peptidsammensætning og anvendelser deraf
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
EP2953116A4 (en) Display apparatus and device
DK2961835T3 (da) Ny bakteriophag og antibakteriel sammensætning omfattende samme
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK2956476T3 (da) Ligandbindende molekyler og anvendelser deraf
DK3030519T3 (da) Tricykliske benzoxaborol-forbindelser og anvendelser deraf
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf